i get what you're saying HD. I believe these results weren't as inspiring for the market, coupled with the DLT in both secure and in the neuroblastoma trial. On top add the being in the index. I feel there has been some leakiness of results.
I think the positive for me is that the fundamentally SP movement may have been due to the the readouts of secure and neuroblastoma. Long term, I still think there are significant positives that the market is dismissing due to the nature of length of trials.
short term, I believe there isn't much else to knock it down
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.39 |
Change
0.300(14.4%) |
Mkt cap ! $768.3M | |||
| Open | High | Low | Value | Volume |
| $2.09 | $2.40 | $2.07 | $8.519M | 3.760M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $2.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.39 | 4380 | 2 |
View Market Depth
| Last trade - 16.21pm 26/06/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |